Nomura Holdings’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Sell |
5,374
-8
| -0.1% | -$1.57K | ﹤0.01% | 1321 |
|
|
2026
Q1 | $1.05M | Buy |
5,382
+4,120
| +326% | +$800K | ﹤0.01% | 1142 |
|
|
2025
Q4 | $219K | Sell |
1,262
-5,013
| -80% | -$913K | ﹤0.01% | 1750 |
|
|
2025
Q3 | $1.2M | Buy |
+6,275
| New | +$1.11M | ﹤0.01% | 1337 |
|
|
2025
Q2 | – | Sell |
-3,509
| Closed | -$594K | – | 1575 |
|
|
2025
Q1 | $594K | Sell |
3,509
-165
| -4% | -$27.1K | ﹤0.01% | 1434 |
|
|
2024
Q4 | $554K | Buy |
+3,674
| New | +$571K | ﹤0.01% | 1752 |
|
|
2024
Q3 | – | Sell |
-1,607
| Closed | -$220K | – | 1629 |
|
|
2024
Q2 | $220K | Buy |
+1,607
| New | +$220K | ﹤0.01% | 1587 |
|
|
2024
Q1 | – | Sell |
-2,278
| Closed | -$314K | – | 1712 |
|
|
2023
Q4 | $314K | Buy |
+2,278
| New | +$299K | ﹤0.01% | 1472 |
|
|
2023
Q3 | – | Sell |
-5,014
| Closed | -$668K | – | 1435 |
|
|
2023
Q2 | $705K | Buy |
+5,014
| New | +$691K | ﹤0.01% | 988 |
|
|
2022
Q1 | – | Sell |
-12,134
| Closed | -$2.1M | – | 2053 |
|
|
2021
Q4 | $2.1M | Sell |
12,134
-29,726
| -71% | -$4.52M | 0.01% | 986 |
|
|
2021
Q3 | $6M | Buy |
+41,860
| New | +$6.12M | 0.01% | 564 |
|
|
2021
Q1 | – | Sell |
-6,246
| Closed | -$744K | – | 1973 |
|
|
2020
Q4 | $744K | Buy |
6,246
+2,913
| +87% | +$355K | ﹤0.01% | 1130 |
|
|
2020
Q3 | $380K | Sell |
3,333
-1,624
| -33% | -$192K | ﹤0.01% | 1063 |
|
|
2020
Q2 | $564K | Buy |
+4,957
| New | +$526K | ﹤0.01% | 857 |
|
|
2019
Q3 | – | Sell |
-15,697
| Closed | -$1.6M | – | 1224 |
|
|
2019
Q2 | $1.6M | Buy |
+15,697
| New | +$1.51M | 0.01% | 719 |
|
|
2019
Q1 | – | Sell |
-49,124
| Closed | -$4.08M | – | 1171 |
|
|
2018
Q4 | $4.08M | Sell |
49,124
-9,976
| -17% | -$935K | 0.02% | 559 |
|
|
2018
Q3 | $6.41M | Sell |
59,100
-28,504
| -33% | -$3.13M | 0.02% | 444 |
|
|
2018
Q2 | $9.63M | Buy |
87,604
+65,392
| +294% | +$6.81M | 0.03% | 379 |
|
|
2018
Q1 | $2.23K | Buy |
22,212
+13,412
| +152% | +$1.37M | ﹤0.01% | 809 |
|
|
2017
Q4 | $867K | Sell |
8,800
-4,765
| -35% | -$452K | ﹤0.01% | 1157 |
|
|
2017
Q3 | $1.27M | Sell |
13,565
-943
| -6% | -$100K | ﹤0.01% | 978 |
|
|
2017
Q2 | $1.61M | Buy |
14,508
+9,607
| +196% | +$1.02M | ﹤0.01% | 898 |
|
|
2017
Q1 | $481K | Sell |
4,901
-6,857
| -58% | -$654K | ﹤0.01% | 931 |
|
|
2016
Q4 | $1.08M | Buy |
+11,758
| New | +$1.01M | ﹤0.01% | 1040 |
|
|
2016
Q2 | – | Sell |
-3,066
| Closed | -$220K | – | 1320 |
|
|
2016
Q1 | $220K | Buy |
+3,066
| New | +$206K | ﹤0.01% | 1195 |
|
|
2015
Q3 | – | Sell |
-46,128
| Closed | -$3.35M | – | 1703 |
|
|
2015
Q2 | $3.35M | Buy |
+46,128
| New | +$3.41M | 0.01% | 588 |
|
|
2015
Q1 | – | Sell |
-14,223
| Closed | -$950K | – | 1880 |
|
|
2014
Q4 | $950K | Buy |
14,223
+8,407
| +145% | +$530K | ﹤0.01% | 1384 |
|
|
2014
Q3 | $353K | Sell |
5,816
-8,080
| -58% | -$498K | ﹤0.01% | 2070 |
|
|
2014
Q2 | $817K | Sell |
13,896
-16,798
| -55% | -$984K | ﹤0.01% | 1532 |
|
|
2014
Q1 | $1.77M | Sell |
30,694
-154,163
| -83% | -$8.26M | ﹤0.01% | 1236 |
|
|
2013
Q4 | $9.9M | Buy |
184,857
+154,405
| +507% | +$9.16M | 0.05% | 228 |
|
|
2013
Q3 | $1.88M | Sell |
30,452
-6,489
| -18% | -$388K | 0.01% | 855 |
|
|
2013
Q2 | $2.24M | Buy |
+36,941
| New | +$2.2M | 0.02% | 630 |
|
Other funds holding DGX
EIG
Nomura Holdings's DGX Position: Q2 2026 in Review
Nomura Holdings reduced its Quest Diagnostics (DGX) stake by 0.15% in Q2 2026, selling an estimated $1.57K and leaving 5,374 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1321.
Nomura Holdings first reported a position in DGX in Q2 2013 and has held it in 33 quarters since. The position peaked at $9.9M in Q4 2013. 1,046 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Nomura Holdings held 5,374 shares of Quest Diagnostics worth $1.14M as of Q2 2026.
- Nomura Holdings sold 8 Quest Diagnostics shares in Q2 2026, an estimated $1.57K.
- Quest Diagnostics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1321 holding.
- Nomura Holdings first reported a position in Quest Diagnostics in Q2 2013 and has held it in 33 quarters since.
- Nomura Holdings's Quest Diagnostics position peaked at $9.9M in Q4 2013.
- 1,046 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.